Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL1400002	重组人抗肿瘤坏死因子-α单克隆抗体注射液	adalimumab	Injection	Biological Products(2)	New Drug Application	2014-02-17	信达生物制药（苏州）有限公司	Innovent Biologics (Suzhou) Co Ltd	Certificate Issued	2016-01-13	view
CXSL1400005	重组人抗肿瘤坏死因子-α单克隆抗体注射液	adalimumab	Injection	Biological Products(2)	New Drug Application	2014-02-19	信达生物制药（苏州）有限公司	Innovent Biologics (Suzhou) Co Ltd	Certificate Issued	2016-01-13	view
CXSB1700005	重组人抗肿瘤坏死因子-α单克隆抗体注射液	adalimumab	Injection	Biological Products	Supplementary Application	2017-08-18	信达生物制药（苏州）有限公司	Innovent Biologics (Suzhou) Co Ltd	Certificate Issued	2018-01-17	view